Literature DB >> 33312461

Severity of Mitral Regurgitation before and after Kidney Transplantation.

G Pourmand1, S Karbalai Saleh2, A Mehrsai1, S Gooran1, M R Khajavi1, E Razeghi1, M Rahbar1, M Pourhossein1, S Dehghani1.   

Abstract

BACKGROUND: Perivalvular and valve involvement are prevalent in patients with end-stage renal disease (ESRD), especially in younger patients compared with normal population. Kidney transplantation improves the prognosis of these patients. Patients with cardiac valvular disease is also be improved following kidney transplantation.
OBJECTIVE: To evaluate the impact of renal transplantation on the severity of mitral regurgitation (MR).
METHODS: We studied 95 kidney transplantation candidates in Sina Hospital. The patients underwent echocardiography preoperatively and at the 3rd, 6th, and 12th months post-operatively.
RESULTS: Pre-operatively, the average MR fraction was 30%; MR volume 30 mL/beat; mitral valve mean gradient 1.8 mm Hg; mitral valve area 4.6 cm2; and mitral annular size 3 cm. No significant difference was observed among the measurements made at the 3rd, 6th, and 12th months post-operatively.
CONCLUSION: There was no significant association between the variables measured pre- and post-operatively. The reason might be the fact that patients with ESRD in Iran do not have to expect long transplant waiting lists and dialysis cannot affect their heart adversely.

Entities:  

Keywords:  Mitral regurgitation; Renal dysfunction; Renal/kidney transplantation

Year:  2019        PMID: 33312461      PMCID: PMC7722517     

Source DB:  PubMed          Journal:  Int J Organ Transplant Med        ISSN: 2008-6482


  10 in total

1.  Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.

Authors:  A Lumiaho; R Ikäheimo; R Miettinen; L Niemitukia; T Laitinen; A Rantala; E Lampainen; M Laakso; J Hartikainen
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

Review 2.  Mitral annular calcification: clinical, pathophysiology, and echocardiographic review.

Authors:  P F Nestico; N L Depace; J Morganroth; M N Kotler; J Ross
Journal:  Am Heart J       Date:  1984-05       Impact factor: 4.749

3.  Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis.

Authors:  E Straumann; B Meyer; M Misteli; A Blumberg; H R Jenzer
Journal:  Br Heart J       Date:  1992-03

4.  Disappearance of mitral and tricuspid regurgitation in haemodialysis patients after ultrafiltration.

Authors:  M Cirit; M Ozkahya; C S Cinar; E Ok; S Aydin; F Akçiçek; E J Dorhout Mees
Journal:  Nephrol Dial Transplant       Date:  1998-02       Impact factor: 5.992

Review 5.  Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population.

Authors:  Sahar Kajbaf; John P Veinot; Andrew Ha; Deborah Zimmerman
Journal:  Am J Kidney Dis       Date:  2005-07       Impact factor: 8.860

6.  Mitral anular calcification in chronic renal failure.

Authors:  M B Forman; R Virmani; R M Robertson; W J Stone
Journal:  Chest       Date:  1984-03       Impact factor: 9.410

Review 7.  The scope of coronary heart disease in patients with chronic kidney disease.

Authors:  Fadi G Hage; Rajesh Venkataraman; Gilbert J Zoghbi; Gilbert J Perry; Angelo M DeMattos; Ami E Iskandrian
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

8.  The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.

Authors:  Jeffrey Rand Rubel; Edgar Louis Milford
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

9.  Prevalence and severity of Doppler-detected valvular regurgitation and estimation of right-sided cardiac pressures in patients with normal two-dimensional echocardiograms.

Authors:  C J Lavie; K Hebert; M Cassidy
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

10.  Doppler echocardiographic assessment of valvular heart disease in patients requiring hemodialysis for end-stage renal disease.

Authors:  J Stinebaugh; C J Lavie; R V Milani; M M Cassidy; J E Figueroa
Journal:  South Med J       Date:  1995-01       Impact factor: 0.954

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.